Description of Posner Schlossman Syndrome Patients in Bandung, Indonesia during the Period of August 2009 to July 2011

Authors

  • Kavitha Arunasalam
  • Erna Tjahjaningtyas
  • RA.Retno Ekowati

Keywords:

Eye vision, Posner Schlossman Syndrome, National Eye Centre Cicendo Eye Hospital

Abstract

   Background: Posner-Schlossman Syndrome (PSS) is also known as Glaucomatocyclitic Crisis. It is a non–genetic, often misdiagnosed, and rare disease characterized by recurrent unilateral episodes of markedly elevated intraocular pressure which occurs simultaneously with mild inflammation of the uvea. The underlying cause of this disease is still unknown. This syndrome usually affects those who are 20 to 50 years old. The aim of this study was to perform a descriptive study on subjects diagnosed with PSS at the National Eye Centre Cicendo Eye Hospital Bandung Indonesia. 

Methods: The method used was a descriptive study carried out on subjects diagnosed with PSS at the National Eye Centre Cicendo Eye Hospital Bandung, Indonesia during the period of August 2009 to July 2011.

Results: Of 31 patients, 19 (61.3%) female patients participated in the study, 12 (38.7%) aged 31–40 years, 9 (29.0%) had recurrences. All (100%) complained of blurred vision, 24 (77.4%) with accompanying vision of rainbow halo surrounding light in, and 22 (71%) had headache. A total of 27 (87.1%) patients suffered from the disease unilaterally. After treatment, 17 (54.8%) patients’ visual acuity improved and 20 (64.4%) patients’ intraocular pressure (IOP) were in normal range. 

Conclusions: PSS mostly affects females. The most prevalent age range is 31–40 years. Most are affected unilaterally. All of them present with the symptom of  blurred vision. Visual acuity and IOP are in normal limit after treatment.

Keywords:  Eye vision, Posner Schlossman Syndrome, National Eye Centre Cicendo Eye Hospital

DOI: 10.15850/amj.v2n1.421 

Downloads

Published

2015-05-01

Issue

Vol. 2 No. 1 (2015)

Section

Articles

License

  1. Authors retain copyright and grant Althea Medical Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in Althea Medical Journal. Althea Medical Journal is licensed under CC BY-NC 4.0
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Althea Medical Journal.